IMMUNATE

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Finland, Hong Kong, Croatia, Lithuania, Malta, Poland, Romania, Tunisia, Turkey, South Africa

Active ingredients

The drug IMMUNATE contains one active pharmaceutical ingredient (API):

1 Coagulation factor VIII and Von Willebrand factor UNII 5T6B772R4Q - HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies. Read about Coagulation factor VIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD04	Coagulation factor IX	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD04
B02BD06	Von Willebrand factor and coagulation factor VIII in combination	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501121010034417, 501121010034517, 501121010034617
Country: EE	Ravimiamet	Identifier(s): 1038079, 1038091, 1349232
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 541183
Country: HK	Department of Health Drug Office	Identifier(s): 57835, 58390
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-927359696
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004579, 1004580, 1004581
Country: MT	Medicines Authority	Identifier(s): MA162/00701, MA162/00702, MA162/00703
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100160309, 100160315, 100160338
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62886001, W62887001, W62888001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10623021H, 10623022H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681429550134, 8681429550141
Country: ZA	Health Products Regulatory Authority	Identifier(s): A40/30.3/0215, A40/30.3/0216, A40/30.3/0217